SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-017566
Filing Date
2022-08-18
Accepted
2022-08-17 19:01:10
Documents
12
Period of Report
2022-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20220815.htm   iXBRL 8-K 54958
  Complete submission text file 0000950170-22-017566.txt   172603

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20220815.xsd EX-101.SCH 2469
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20220815_pre.xml EX-101.PRE 9840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20220815_lab.xml EX-101.LAB 13342
6 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20220815_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 221175851
SIC: 2834 Pharmaceutical Preparations